Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
Some compounds reported as active against SARS CoV were selected, and docking studies were performed using the main protease of SARS CoV-2 as the receptor. The docked complex analysis shows that the ligands selectively bind with the target residues and binding affinity of amentoflavone (–10.1 kcal m...
Saved in:
Main Authors: | EBENEZER OLUWAKEMI, SHAPI MICHAEL |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2022-0020 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis
by: Ganesh Sharma, et al.
Published: (2025-01-01) -
In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley Data
by: Mariyam Eema, et al.
Published: (2025-04-01) -
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
by: Qian Wang, et al.
Published: (2024-10-01) -
Evaluation of COVID-19 protease and HIV inhibitors interactions
by: Tran Linh, et al.
Published: (2022-03-01) -
Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01)